Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
443.16
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
72
73
Next >
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
↗
August 23, 2024
Via
Benzinga
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
↗
August 23, 2024
Vertex Pharmaceuticals has a lot going for it.
Via
The Motley Fool
Vertex to Participate in Upcoming September Investor Conferences
August 22, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
↗
August 21, 2024
Via
Benzinga
Biotech Bull Market: 3 Ways To Play It
↗
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
↗
August 09, 2024
Via
Benzinga
Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook
↗
August 01, 2024
The company's sales came in a hair light with losses wider than expected.
Via
Investor's Business Daily
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
↗
August 19, 2024
Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities...
Via
Benzinga
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
↗
August 18, 2024
It's always a good time to invest cash in quality businesses.
Via
The Motley Fool
3 Fantastic Growth Stocks to Buy in August
↗
August 17, 2024
These stocks should keep up their winning ways.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 15, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
↗
August 15, 2024
These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning.
Via
InvestorPlace
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
↗
August 15, 2024
These technologies could be game-changers. And they could make forward-thinking investors a lot of money.
Via
The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in August
↗
August 12, 2024
Both of these biotechs are highly innovative companies.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in August 2024
↗
August 08, 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.
Via
InvestorPlace
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
August 07, 2024
From
Vertex Pharmaceuticals
Via
Business Wire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
↗
August 06, 2024
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
↗
August 05, 2024
Great companies are found in every type of market landscape.
Via
The Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
↗
August 04, 2024
Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!
Via
InvestorPlace
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
↗
August 04, 2024
The biotech recently became a commercial-stage company.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
↗
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
↗
August 03, 2024
These two healthcare companies have far more upside potential than Johnson & Johnson.
Via
The Motley Fool
3 Biotech Stocks That Could Have Investors Grinning Soon
↗
August 02, 2024
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Via
InvestorPlace
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
↗
August 02, 2024
Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and...
Via
Benzinga
Topics
Economy
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
↗
August 02, 2024
Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain...
Via
Benzinga
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
↗
August 02, 2024
Vertex's first loss in years is a big nothingburger.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
↗
August 01, 2024
VRTX earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Vertex Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
↗
August 01, 2024
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...
Via
Benzinga
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
↗
August 01, 2024
These businesses are looking like increasingly attractive buys.
Via
The Motley Fool
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
